InvestorsHub Logo
Followers 62
Posts 2098
Boards Moderated 0
Alias Born 05/09/2020

Re: Blue Man post# 213433

Friday, 08/05/2022 3:04:11 PM

Friday, August 05, 2022 3:04:11 PM

Post# of 232169
And what I find interesting is that Scott Kelly's very first Form 3 with CytoDyn from when he became a director in April 2017 has Deborah Kelly coming on the radar by already owning 691,208 shares.

https://www.sec.gov/Archives/edgar/data/0001703394/000089924317010063/xslF345X03/doc3.xml

So....Deborah Kelly has been HODLING for over 5 years now and has been accumulating...

What kind of doctor is she.....let's see...

Board certified in Internal Medicine in 1998......
An Adjunct Associate Professor of Medicine at Emory School of Medicine.....
A Fellow of American College of Physicians.....
Active in the American College of Physicians-American Society of Internal Medicine, the American Medical Association, and the Royal College of Physicians....
Attended the Lovett School in Atlanta....
Graduated Cum Laude from Wake Forest University....
Attended Medical School at the Medical College of Georgia....
Completed internship and residency at Emory University School of Medicine....

That sounds like a very qualified medical doctor and someone who understands quite a bit about of why leronlimab can be beneficial in medicine...

Deborah "HODLING" Kelly, MD, FACP

I can't go to Hell as everyone keeps saying...Satan has a restraining order against me....

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News